Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia189
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery139
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor78
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece77
Lipoprotein(a) concentrations across a global cross-sectional registry77
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories73
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study66
Care of youth with lipid disorders: A brief provider survey62
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis60
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection57
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis57
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse51
The Effect of Estrogen and Testosterone on Cholesterol Crystallization48
News from NLA47
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine47
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss40
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database37
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes36
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease34
Evidence of Direct Hepatic Secretion of Low density Lipoprotein (LDL) in Mice34
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease31
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study31
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report31
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the Americ30
Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia: A systematic review and meta-analysis30
Exciting new developments in clinical lipidology: Updates from the Food and Drug Administration and the American Heart Association29
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association29
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia28
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders28
0.15819597244263